MedPath

Albuterol Sulfate

Albuterol Sulfate Inhalation Solution, 0.083% 2.5 mg/3 mL (RDP)

Approved
Approval ID

b72742df-1a6b-4483-aff3-3e79db5e015d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2023

Manufacturers
FDA

Ritedose Pharmaceuticals, LLC

DUNS: 968062294

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Albuterol Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76204-200
Application NumberANDA077839
Product Classification
M
Marketing Category
C73584
G
Generic Name
Albuterol Sulfate
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateDecember 20, 2023
FDA Product Classification

INGREDIENTS (1)

ALBUTEROL SULFATEActive
Quantity: 2.5 mg in 3 mL
Code: 021SEF3731
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Albuterol Sulfate - FDA Drug Approval Details